Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
Status:
Completed
Trial end date:
2019-03-04
Target enrollment:
Participant gender:
Summary
This pilot study aims to investigate the diagnostic utility of 18F-DCFPyL, a novel
low-molecular weight PSMA PET/CT imaging agent, in men with an elevated PSA following radical
prostatectomy.
Phase:
N/A
Details
Lead Sponsor:
Sidney Kimmel Comprehensive Cancer Center Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins